demonstrated PTEN knockdown activates the IL-6 inflammatory loop which, in turn, promotes the breast CSC subpopulation in HER2+/trastuzumab-resistant cells, tumor growth, and secondary metastases in vivo (122). The gene discussed is PTEN; the disease is neoplasm.